Stay updated on Sotatercept in PAH High-Risk Mortality Clinical Trial
Sign up to get notified when there's something new on the Sotatercept in PAH High-Risk Mortality Clinical Trial page.

Latest updates to the Sotatercept in PAH High-Risk Mortality Clinical Trial page
- Check6 days agoChange DetectedExpanded the study eligibility to include idiopathic, heritable, drug/toxin-induced, CTD-associated PAH, and post-shunt correction cases, with more detailed baseline criteria and endpoints extending up to ~31 months. Removed the prior requirement of REVEAL Lite 2.0 score ≥9 and the mandate for maximum tolerated background PAH therapy, replacing it with broader inclusion and longer follow-up.SummaryDifference0.6%

- Check13 days agoChange DetectedAdded a dedicated Results section with the NEJM publication citation and updated study dates.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedRevision v3.4.2 was added and v3.4.1 was removed, a minor update to the page's versioning information; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check34 days agoChange DetectedRevision: v3.4.1 is now displayed, replacing Revision: v3.4.0. This metadata update does not change study content, results, or eligibility details.SummaryDifference0.0%

- Check49 days agoChange DetectedStudy results are now posted (NEJM publication) and study record dates updated. Related documentation and links are now visible on the page.SummaryDifference0.1%

- Check56 days agoChange DetectedThe updates appear to be cosmetic changes to the page layout and navigation without modifying the study details, endpoints, or eligibility criteria. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Sotatercept in PAH High-Risk Mortality Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sotatercept in PAH High-Risk Mortality Clinical Trial page.